Our
Partners

We are establishing strategic research partnerships with medical providers and clinics dedicated to advancing regenerative medicine through rigorous scientific investigation. We provide clinicians with access to unique FDA compliant investigational products while implementing structured protocols for comprehensive data collection. These collaborative relationships extend beyond traditional supplier-provider dynamics, positioning clinicians as integral research partners in our mission to validate novel regenerative interventions.

Outcome tracking forms the cornerstone of our collaborative model, with Nova Vita and partner clinicians jointly prioritizing systematic documentation of patient responses across multiple parameters and timepoints. This commitment to robust data collection enables the identification of optimal treatment protocols, refinement of patient selection criteria, and development of evidence-based best practices. Our research partners benefit from standardized assessment tools, dedicated research support, and participation in multi-center investigations examining applications ranging from orthopedic conditions to dermatological rejuvenation.

We are forming strategic alliances with Medical Service Organizations (MSOs) to expand the reach and implementation of our regenerative medicine solutions while maintaining clinical excellence. These partnerships leverage the MSO's operational infrastructure and provider networks alongside Nova Vita's investigational therapeutics. By integrating our research protocols into MSO frameworks, we establish standardized approaches to patient selection, treatment administration, and outcome documentation across multiple practice locations, creating valuable data ecosystems that drive continuous improvement.

Our MSO partnerships are built on shared commitments to both scientific advancement and operational efficiency. Nova Vita provides specialized training, research design support, and access to our portfolio of minimally manipulated therapeutics, while MSO partners contribute their management expertise and scaled implementation capabilities. Together, we develop customized outcome tracking systems that balance research rigor with practical clinical workflows. This collaborative approach allows for the efficient validation of regenerative interventions across diverse patient populations while helping MSO-affiliated practices differentiate their service offerings through evidence-based regenerative options.

Nova Vita Laboratories strategically collaborates with innovative product manufacturers to advance the field of regenerative medicine through complementary scientific expertise and technological capabilities. These partnerships combine Nova Vita's research into molecular signaling pathways and regenerative mechanisms with manufacturers' specialized delivery systems, formulation technologies, and novel instruments. By integrating our knowledge of exosomes, growth factors, and peptide therapeutics with cutting-edge manufacturing platforms, we co-develop next-generation regenerative solutions with enhanced efficacy, stability, and clinical applicability.

Our manufacturer partnerships operate within a framework of scientific rigor and translational focus, with shared commitments to evidence generation and regulatory compliance. Through these strategic alliances, Nova Vita extends our impact on regenerative medicine by transforming scientific discoveries into scalable, consistent therapeutic products designed for real-world clinical implementation and validated through rigorous outcome assessment.